Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-924 in Patients With Hypercholesterolemia
NCT04289649Phase 3Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Apr 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of K-924 in hypercholesterolemia, sponsored by Kowa Company, Ltd.. Started Apr 2020; status: completed.
02
Drugs
K-924
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04289649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04289649.